Cognitive effects of long-term treatment with waking-hour subcutaneous apomorphine infusions in patients with advanced Parkinson's disease

Logo poskytovatele

Varování

Publikace nespadá pod Filozofickou fakultu, ale pod Středoevropský technologický institut. Oficiální stránka publikace je na webu muni.cz.
Autoři

KUBÍKOVÁ Radka TYRLÍK Mojmír REKTOROVÁ Irena

Rok publikování 2011
Druh Článek v odborném periodiku
Časopis / Zdroj Ceska a Slovenska Neurologie a Neurochirurgie
Fakulta / Pracoviště MU

Středoevropský technologický institut

Citace
www http://www.csnn.eu/en/czech-slovak-neurology-article/cognitive-effects-of-long-term-treatment-with-waking-hour-subcutaneous-apomorphine-infusions-in-patients-with-adv-35795?confirm_rules=1
Obor Neurologie, neurochirurgie, neurovědy
Klíčová slova Affective; Apomorphine; Cognitive; Dementia; Parkinson's disease
Přiložené soubory
Popis Aims: To determine whether long-term treatment with continuous subcutaneous apomorphine infusions (CSAI) is safe for patients with Parkinson's disease (PD) with a history of hallucinations and/or marked cognitive deficit. Methods: 12 PD patients (9 men, 3 women; age 71.8 +- 6 years) were given neuropsychological assessment prior to continuous administration of CSAI and fourteen months after it. Results: CSAI led to clinical improvement, at least minimal, in all subjects. However, the treatment led to statistically significant impairment in verbal fluency tasks, the Mattis dementia rating scale (MDRS) score and the attention and initiation subtests. No mood changes were detected. Conclusions: We observed significant impairment in "frontal-like" tasks after continuous treatment with CSAI in our PD patients with baseline cognitive impairment. Further longitudinal controlled studies are needed to assess the impact of both CSAI and PD progression. We suggest cautious selection of patients eligible for CSAI therapy with respect to their cognitive profiles and/or neuropsychiatric complications.
Související projekty:

Používáte starou verzi internetového prohlížeče. Doporučujeme aktualizovat Váš prohlížeč na nejnovější verzi.